Objective:

To explore the relationship between frailty, immune exhaustion, and bone health markers in HIV patients on antiretroviral therapy, emphasizing its clinical significance.

Key Findings:

• Cytokines and chemokines linked to frailty were regulated by NF-κB signaling.
• No association found between frailty and senescence T-cell phenotypes.
• Frailty was associated with increased osteoprotegerin (OPG) levels, linked to immune checkpoint markers, suggesting a potential pathway for therapeutic intervention.

Interpretation:

The study suggests that immune exhaustion and specific inflammatory markers may contribute to frailty in HIV patients, highlighting potential therapeutic targets such as OPG and immune checkpoint inhibitors.

Limitations:

• Potential confounders like depression, smoking, and statin use were not fully accounted for, which may influence the study's findings.
• Correlative nature of the study requires validation through animal models and clinical trials to establish causation.

Conclusion:

Further research is needed to define specific immune markers and explore therapeutic strategies to address frailty in HIV patients, underscoring the clinical importance of this issue.